AXTI stock rockets after AXT's AI-driven Q2 earnings beat
AXTI stock surged after AXT, Inc. reported second-quarter 2026 revenue of $47.6 million and non-GAAP earnings of $0.19 per share, crushing prior-year losses and Wall Street forecasts. Record indium phosphide sales, driven by AI and data-center optical demand, returned the company to profitability and fueled strong Q3 guidance that sent shares sharply higher.
Key Takeaways
- Q2 revenue hit $47.6 million versus $18.0 million a year earlier, with non-GAAP EPS of $0.19 versus a prior-year loss.
- GAAP gross margin expanded to 44.9%, and management cited record indium phosphide revenue tied to optical and AI infrastructure demand.
- AXTI stock jumped after the beat, with reports citing a roughly 37% surge and a sharp after-hours spike.
- Q3 guidance pointed to about $66 million in revenue and non-GAAP EPS of $0.30–$0.32, with backlog above $100 million.
- A long-term Lumentum supply deal through 2031 includes $87 million in deposits for future indium phosphide wafers.
AXT (Nasdaq: AXTI), a maker of compound semiconductor substrates, said the quarter ended June 30, 2026, marked an inflection. CEO Morris Young linked the step-up to data-center optical connectivity demand plus added capacity and productivity gains. For more market-moving alerts, see our Fintech & Crypto Alerts hub.
What did AXT report for second-quarter 2026?
According to the company’s Yahoo Finance release of the Business Wire results, revenue was $47.6 million, up from $26.9 million in Q1 2026 and $18.0 million in Q2 2025.
GAAP net income after minority interests was $11.1 million, or $0.17 diluted EPS, reversing a $1.6 million loss in Q1 and a $7.0 million loss a year earlier. Non-GAAP net income was $11.9 million, or $0.19 per share.
GAAP gross margin reached 44.9% of revenue, versus 29.6% in the prior quarter and 8.0% a year ago. Non-GAAP gross margin was 45.0%.
Why is AXTI stock moving so hard on the print?
Traders focused on the size of the beat and the AI narrative. Market coverage said AXTI delivered $0.19 EPS against a $0.07 consensus and $47.6 million revenue versus about $34.1 million expected. Shares were reported up about 36.69%, after roughly a 20% after-hours spike.
Young said Q2 delivered AXT’s highest quarterly indium phosphide revenue to date. Separate reporting put that InP figure at a record $30.7 million, with capacity fully utilized and backlog above $100 million. Management has targeted gross margins in the “40s” as production stays full.
AXT also highlighted a long-term supply and capacity reservation agreement with Lumentum through 2031, backed by $87 million in deposits against future wafer shipments—another signal that optical and AI-related demand is booked, not just hoped for.
What is AXT guiding for the third quarter?
For Q3, coverage of the call said AXT guided revenue to about $66 million and EPS to $0.30–$0.32, well above then-Street estimates near $38.81 million and $0.10. Management also flagged potential upside if additional export permits for indium phosphide substrates come through.
That outlook helps explain why AXTI stock became a high-volatility AI-infrastructure momentum name in July, with repeated double-digit daily moves into the $50s and $60s reported by traders watching the tape.
What risks still hang over AXTI stock?
Not every Wall Street voice is chasing the rally. B. Riley cut its price target to $52 from $73 and kept a Neutral rating, underscoring valuation and execution debate after the run-up. AXT’s own safe-harbor language also flags export-permit timing, China-related supply-chain complexity, and geopolitical risks.
Still, the core story from the quarter is clear: revenue more than doubled year over year, margins snapped higher, and guidance implies another step-up—enough to keep AXTI stock firmly on traders’ radars.